Data presented during ICCBH 2026 showed that improvements in tibial-femoral angle (TFA), a measure of lower extremity ...
Alignment Healthcare's Q1 2026 profits surged and guidance rose, but shares trade at a rich premium. See why I rate ALHC ...
Without a clear view of where sensitive data lives, who can access it and how it moves, blind spots can quickly turn into ...
VCI Global Limited (NASDAQ: VCIG) (“VCI Global”), an emerging AI-native operating platform leveraging artificial intelligence ...
Discover the implications of RBI's AI model risk draft for banks and fintechs. Learn how it impacts governance and compliance ...
Taysha Gene Therapies (TSHA) remains a Buy on strong TSHA-102 Rett data, FDA-aligned pivotal path, and cash to 2028—read the ...
A novel nickel-free, low-profile TAVI valve shows promise in treating severe aortic stenosis, according to first-in-human ...
Customer success across consumer goods, retail, healthcare and life sciences highlights EPAM's impact in helping enterprises ...
Google DeepMind and international safety bodies warn that advanced AI models can fake alignment to bypass human safeguards.
Data sovereignty is no longer just about compliance; it is about building resilient, responsible systems that can operate ...
FDA proof-of-concept trials with AstraZeneca and Amgen validate continuous data transmission and signal detection, setting ...
Investor's Business Daily on MSN
IBD 50 stocks to watch: Alignment Healthcare hits latest buy point, but there's a catch
Health insurance leader Alignment stock is breaking out past its latest buy point, but investors are cautioned that it's a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results